Cannabis for Migraines

Cannabis for Migraines: A Complete Patient Guide

An authoritative, evidence-based overview of how cannabis may help migraine sufferers — including best strains, delivery methods, dosing guidance, and what current research says.

Understanding Migraines

A migraine is far more than a severe headache. It is a complex neurological disorder characterized by recurring attacks of moderate-to-severe throbbing or pulsating head pain, typically on one side of the head, lasting anywhere from 4 to 72 hours. Migraines are frequently accompanied by nausea, vomiting, and extreme sensitivity to light (photophobia) and sound (phonophobia). Approximately one-third of sufferers also experience an "aura" — transient neurological symptoms such as visual disturbances, tingling, or speech difficulties — that precede or accompany the headache phase.

The condition is believed to arise from abnormal brain activity that temporarily alters nerve signals, brain chemicals, and blood flow in the brain. Triggers are highly individual and can include hormonal changes, stress, certain foods and drinks, sensory stimuli, sleep disruption, and weather changes. Women are disproportionately affected, accounting for roughly 75% of migraine sufferers.

Conventional treatments fall into two broad categories: acute (abortive) therapies and preventive therapies. Acute options include over-the-counter NSAIDs, acetaminophen, triptans (such as sumatriptan and rizatriptan), ergotamines, and — for severe attacks — gepants or ditans. Preventive medications include beta-blockers, anticonvulsants (topiramate, valproate), tricyclic antidepressants, and CGRP monoclonal antibodies such as erenumab and fremanezumab.

Limitations of conventional care are significant. Triptans — the gold-standard abortive — are contraindicated in patients with cardiovascular disease and cause rebound headaches in some users. Up to 50% of patients report inadequate relief from first-line treatments. Preventive medications carry side-effect profiles that affect tolerability, including weight gain, cognitive slowing, and fatigue. These gaps have driven a growing number of patients to explore cannabis as a complementary or alternative therapy, as documented in surveys from the medical cannabis literature.

How Cannabis May Help Migraines

The human body's endocannabinoid system (ECS) plays a central role in pain modulation, inflammation, and neurological regulation — all processes directly implicated in migraine pathophysiology. The ECS consists of endogenous cannabinoids (primarily anandamide and 2-AG), cannabinoid receptors (CB1 and CB2), and the enzymes that synthesize and degrade them.

Researchers have proposed a "clinical endocannabinoid deficiency" (CECD) hypothesis, originally advanced by neurologist Ethan Russo, MD, suggesting that insufficient ECS tone may underlie conditions like migraine, fibromyalgia, and irritable bowel syndrome. Supporting this, studies have detected lower-than-normal levels of anandamide in the cerebrospinal fluid of chronic migraine patients. Plant-derived cannabinoids — particularly THC and CBD — may supplement endocannabinoid activity, correcting this imbalance.

THC binds primarily to CB1 receptors, which are densely expressed in the trigeminal nucleus caudalis, the key relay station for migraine pain. CB1 activation inhibits the release of pro-inflammatory neuropeptides such as CGRP (calcitonin gene-related peptide) and substance P — the same signaling molecules targeted by the newest class of CGRP migraine drugs. THC also modulates serotonin activity in ways that parallel how triptans work, though through distinct mechanisms.

CBD exerts anti-inflammatory, anxiolytic, and serotonin-modulating effects without the psychoactive high of THC. CBD inhibits FAAH, the enzyme that breaks down anandamide, effectively raising the body's natural endocannabinoid levels. It also antagonizes TRPV1 receptors (pain and temperature sensors) and GPR55 receptors, which have been linked to migraine-related neurological hyperexcitability.

"Migraine may represent the most common clinical endocannabinoid deficiency syndrome, and cannabis remains one of the most promising tools for correcting that deficit — if used thoughtfully and under medical supervision."

Beyond direct receptor activity, cannabis's well-documented antiemetic effects are highly relevant: nausea and vomiting during migraine attacks can be as debilitating as the pain itself, and THC's interaction with CB1 receptors in the brainstem's vomiting center (the dorsal vagal complex) provides meaningful symptom relief for many patients.

Best Strains for Migraines

Strain selection matters considerably for migraine relief. The ideal strain depends on whether a patient is managing an acute attack or seeking preventive daily relief, their tolerance to THC, and their sensitivity to psychoactive effects. The following six strains are frequently cited by migraine patients and cannabis clinicians. Explore each at our full strain library.

Dosage & Delivery Methods

Delivery method is perhaps the most important variable in migraine management with cannabis, because onset time and duration of effect differ dramatically between routes of administration. For acute attacks, speed is critical — the faster cannabinoids reach the bloodstream, the greater the chance of aborting or blunting the attack before it peaks. For prevention, longer-acting methods with stable blood levels are preferred. Always begin with the lowest effective dose and titrate slowly — a principle known as "start low, go slow" — especially if you are new to cannabis or are combining it with other migraine medications. Learn more in our cannabis dosing explainer.